Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank E Mott

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Clinical Lung Cancer|July 25, 2008
Brain metastases in N2-positive non-small-cell lung cancer: implications for prophylactic cranial irradiationMohit Bansal, Teresa Boyle, Alex Ehsan, et al.
Supportive Cancer Therapy|July 17, 2008
Tumor lysis syndrome in solid tumorsFrank E Mott, Alex Esana, Carl Chakmakjian, et al.
Laryngoscope Investigative Otolaryngology|December 28, 2020
Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI)Frank E Mott, Ruth Sacks, Faye Johnson, et al.
Oncoimmunology|November 20, 2019
Predictors of benefits from frontline chemoimmunotherapy in stage IV non-small-cell lung cancer: a meta-analysisHazem E El-Osta, Frank E Mott, Bryan M Burt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2020
Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer centerRichard C Cardoso, Mona Kamal, Jhankruti Zaveri, et al.
Clinical Lung Cancer|April 25, 2018
Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation TherapyCharissa R Kim, Bumyang Kim, Matthew S Ning, et al.
JTO Clinical and Research Reports|November 25, 2021
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With <i>EGFR</i> or <i>ALK</i> AlterationsWhitney E Lewis, Lingzhi Hong, Frank E Mott, et al.
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the LiteratureFelipe Soto, Luis F Torre-Sada, Frank E Mott, et al.
Cancer|May 2, 2023
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancerMehmet Altan, Janet Tu, Denái R Milton, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 6, 2021
Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal CancerPuja Aggarwal, Katherine A Hutcheson, Adam S Garden, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Clinical Lung Cancer|July 25, 2008
Brain metastases in N2-positive non-small-cell lung cancer: implications for prophylactic cranial irradiationMohit Bansal, Teresa Boyle, Alex Ehsan, et al.
Supportive Cancer Therapy|July 17, 2008
Tumor lysis syndrome in solid tumorsFrank E Mott, Alex Esana, Carl Chakmakjian, et al.
Laryngoscope Investigative Otolaryngology|December 28, 2020
Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI)Frank E Mott, Ruth Sacks, Faye Johnson, et al.
Oncoimmunology|November 20, 2019
Predictors of benefits from frontline chemoimmunotherapy in stage IV non-small-cell lung cancer: a meta-analysisHazem E El-Osta, Frank E Mott, Bryan M Burt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2020
Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer centerRichard C Cardoso, Mona Kamal, Jhankruti Zaveri, et al.
Clinical Lung Cancer|April 25, 2018
Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation TherapyCharissa R Kim, Bumyang Kim, Matthew S Ning, et al.
JTO Clinical and Research Reports|November 25, 2021
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With <i>EGFR</i> or <i>ALK</i> AlterationsWhitney E Lewis, Lingzhi Hong, Frank E Mott, et al.
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the LiteratureFelipe Soto, Luis F Torre-Sada, Frank E Mott, et al.
Cancer|May 2, 2023
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancerMehmet Altan, Janet Tu, Denái R Milton, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 6, 2021
Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal CancerPuja Aggarwal, Katherine A Hutcheson, Adam S Garden, et al.
Pageof 4